These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 16822479

  • 1. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
    Balan KV, Wang Y, Chen SW, Chen JC, Zheng LF, Yang L, Liu ZL, Pantazis P, Wyche JH, Han Z.
    Biochem Pharmacol; 2006 Aug 28; 72(5):573-81. PubMed ID: 16822479
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition.
    Balan KV, Wang Y, Chen SW, Pantazis P, Wyche JH, Han Z.
    Biochem Pharmacol; 2006 Aug 28; 72(5):566-72. PubMed ID: 16806088
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 4. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells.
    Lu IF, Hasio AC, Hu MC, Yang FM, Su HM.
    J Nutr Biochem; 2010 Jun 15; 21(6):512-7. PubMed ID: 19369047
    [Abstract] [Full Text] [Related]

  • 5. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 15; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 6. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
    Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y.
    Cancer Sci; 2006 Nov 15; 97(11):1198-204. PubMed ID: 16925584
    [Abstract] [Full Text] [Related]

  • 7. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J, Flament S, Salamone S, Boisbrun M, Mazerbourg S, Chapleur Y, Grillier-Vuissoz I.
    Breast Cancer Res Treat; 2008 Dec 15; 112(3):437-51. PubMed ID: 18204896
    [Abstract] [Full Text] [Related]

  • 8. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
    Lu J, Pierron A, Ravid K.
    Cancer Res; 2003 Oct 01; 63(19):6413-23. PubMed ID: 14559831
    [Abstract] [Full Text] [Related]

  • 9. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE, Weebadda W, Ung K, Murphy LC.
    Breast Cancer Res Treat; 2009 Nov 01; 118(2):269-79. PubMed ID: 18941890
    [Abstract] [Full Text] [Related]

  • 10. Temporal variation in estrogen receptor-alpha protein turnover in the presence of estrogen.
    Valley CC, Solodin NM, Powers GL, Ellison SJ, Alarid ET.
    J Mol Endocrinol; 2008 Jan 01; 40(1):23-34. PubMed ID: 18096994
    [Abstract] [Full Text] [Related]

  • 11. Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells.
    Laïos I, Cleeren A, Leclercq G, Nonclercq D, Laurent G, Schlenk M, Wellner A, Gust R.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1029-38. PubMed ID: 17706611
    [Abstract] [Full Text] [Related]

  • 12. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A, Brodie AM, Njar VC.
    Cancer Res; 2006 Dec 01; 66(23):11485-93. PubMed ID: 17145897
    [Abstract] [Full Text] [Related]

  • 13. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
    Rachner TD, Schoppet M, Niebergall U, Hofbauer LC.
    Biochem Biophys Res Commun; 2008 Apr 11; 368(3):736-41. PubMed ID: 18252198
    [Abstract] [Full Text] [Related]

  • 14. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
    Collier ME, Li C, Ettelaie C.
    Mol Cancer Res; 2008 Dec 11; 6(12):1807-18. PubMed ID: 19074826
    [Abstract] [Full Text] [Related]

  • 15. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I.
    Mol Cancer; 2006 Nov 05; 5():57. PubMed ID: 17083744
    [Abstract] [Full Text] [Related]

  • 16. Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells.
    Azuma K, Urano T, Horie-Inoue K, Hayashi S, Sakai R, Ouchi Y, Inoue S.
    Cancer Res; 2009 Apr 01; 69(7):2935-40. PubMed ID: 19318565
    [Abstract] [Full Text] [Related]

  • 17. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z, Reierstad S, Huang CC, Bulun SE.
    Cancer Res; 2007 May 15; 67(10):5017-24. PubMed ID: 17510434
    [Abstract] [Full Text] [Related]

  • 18. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N, Jansson D, Mader S, Pratt MA.
    J Cell Biochem; 2009 Jun 01; 107(3):448-59. PubMed ID: 19350539
    [Abstract] [Full Text] [Related]

  • 19. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
    Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C, Chun K, Hennessy B, Mills GB, Nawaz Z, Slingerland JM.
    J Clin Invest; 2007 Aug 01; 117(8):2205-15. PubMed ID: 17627304
    [Abstract] [Full Text] [Related]

  • 20. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR, Allred CD, Zaytseva YY, Kilgore MW.
    Breast Cancer Res Treat; 2008 Mar 01; 108(1):23-33. PubMed ID: 17453334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.